Retinoblastoma
Retinoblastoma is a cancer that starts in the retina, It is the most common type of eye cancer in children. The obvious sign of retinoblastoma is an unusual appearance of the retina as viewed through the pupil, the medical term for which is leukocoria, also known as amaurotic cat's eye reflex. Other signs and symptoms include deterioration of vision, a red and irritated eye with glaucoma, and faltering development or delayed development. Some children with retinoblastoma can develop a cross-eyed. Retinoblastoma presents with advanced disease in emerging countries and eye enlargement is a common finding.
Related Conference of Retinoblastoma
November 25-26, 2024
7th International Conference on Anti-Cancer Drugs & Therapies
Vancouver, Canada
April 21-22, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Amsterdam, Netherlands
Retinoblastoma Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advanced Oncology & Radiology Techniques - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Advanced Therapies in Cancer - CANCER THERAPY MEETING 2024 (France)
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2024 (France)
- Advancements in Oncology Nursing: Trends and Best Practicss - World Cancer 2025 (UK)
- Advancements in Tumor Microenvironment Targeting - Cancer Biology 2025 (UK)
- Advances in Cancer Biomarkers - Biomarkers Conference 2025 (Italy)
- Advances in Cancer Prevention and Risk Assessment - Preventive Oncology 2025 (Italy)
- Advances in Cancer Research and Treatment - Cancer Drugs 2024 (Canada)
- Advances in Cell-Based Drug Delivery Systems - Cancer Biology 2025 (UK)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2024 (France)
- AI and Machine Learning in Cancer Care - CANCER2025 (Netherlands)
- Alternative Treatments and Therapeutics - Cancer Science 2024 (Italy)
- Anti-cancer Drug Discovery - CANCER THERAPY MEETING 2024 (France)
- Anti-Cancer Drug Discovery and Development - Cancer Drugs 2024 (Canada)
- Autophagy and Cancer Cell Survival Mechanisms - Cancer Biology 2025 (UK)
- Basic and Translational Research - ORAL CANCER SUMMIT 2025 (France)
- Bioinformatics and Biomarkers - Biomarkers Conference 2025 (Italy)
- Biomarker Detection Technologies - Biomarkers Conference 2025 (Italy)
- Biomarkers in Drug Development - Biomarkers Conference 2025 (Italy)
- Biopsy in Cancer Diagnosis: - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Breast Cancer - Cancer Science 2024 (Italy)
- Breast Cancer - Euro Cancer 2024 (Italy)
- Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Breast Cancer and Cell Biology - Breast Cancer 2024 (France)
- Breast cancer and cell biology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer And Immunology - Breast Cancer 2024 (France)
- Breast Cancer And Immunology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Awareness - Breast Cancer 2024 (France)
- Breast Cancer Awareness - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer 2024 (France)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer Summit 2025 (Italy)
- Breast Cancer during pregnancy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Management - Breast Cancer 2024 (France)
- Breast Cancer Nursing - Breast Cancer 2024 (France)
- Breast Cancer Nursing - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Radiation Therapy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Risk - Breast Cancer 2024 (France)
- Breast Cancer Risk - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Staging - Breast Cancer 2024 (France)
- Breast Cancer Surgery - Breast Cancer 2024 (France)
- Breast cancer surgery - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Therapies - Breast Cancer Summit 2025 (Italy)
- Breast Cancer- Clinical Trails - Breast Cancer Summit 2025 (Italy)
- Breast Cancer-Clinical Trials - Breast Cancer 2024 (France)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (Netherlands)
- Breast carcinoma/Breast cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cancer & Stem Cell Therapy - Euro Cancer 2024 (Italy)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2025 (France)
- Cancer and its Relevance with other Diseases - Cancer Drugs 2024 (Canada)
- Cancer Awareness and Survival - Cancer Meeting Summit 2025 (France)
- Cancer Biomarkers - Cancer Science 2024 (Italy)
- Cancer Biomarkers - Euro Cancer 2024 (Italy)
- Cancer Biomarkers - Cancer Meeting Summit 2025 (France)
- Cancer Biomarkers & Bioinformatics - Cancer Drugs 2024 (Canada)
- Cancer Biopsy - Cancer Meeting Summit 2025 (France)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2024 (France)
- Cancer Case reports - Euro Cancer 2024 (Italy)
- Cancer Causes & Risk Factors - Cancer Drugs 2024 (Canada)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2025 (France)
- Cancer Cell Signaling - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cancer Control and Prevention - Cancer Science 2024 (Italy)
- Cancer Diagnosis - Euro Cancer 2024 (Italy)
- Cancer Diagnosis and Screening - Cancer Science 2024 (Italy)
- Cancer Diagnostics - World Cancer 2025 (UK)
- Cancer Diagnostics and Emerging Technologies - CANCER THERAPY MEETING 2024 (France)
- Cancer Drugs - Euro Cancer 2024 (Italy)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2025 (France)
- Cancer Epidemiology - Cancer Drugs 2024 (Canada)
- Cancer Epidemiology - Euro Cancer 2024 (Italy)
- Cancer Epidemiology and Biomarkers - Preventive Oncology 2025 (Italy)
- Cancer Epidemiology and Public Health - World Cancer 2025 (UK)
- Cancer Epigenetics - Cancer Science 2024 (Italy)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2024 (France)
- Cancer Genomics and Epigenetics - CANCER THERAPY MEETING 2024 (France)
- Cancer Genomics and Precision Oncology - Preventive Oncology 2025 (Italy)
- Cancer Health Disparities - CANCER THERAPY MEETING 2024 (France)
- Cancer Imaging - Euro Cancer 2024 (Italy)
- Cancer Immunology - CANCER THERAPY MEETING 2024 (France)
- Cancer Immunology & Immunotherapy - Cancer Drugs 2024 (Canada)
- Cancer Immunology & Immunotherapy - Euro Cancer 2024 (Italy)
- Cancer Immunology and Immunotherapy - World Cancer 2025 (UK)
- Cancer Immunology and Immunotherapy - Preventive Oncology 2025 (Italy)
- Cancer Metabolism - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (Netherlands)
- Cancer Metastasis - Cancer Science 2024 (Italy)
- Cancer Nanotechnology - Cancer Drugs 2024 (Canada)
- Cancer Pathology & Genetics - Cancer Drugs 2024 (Canada)
- Cancer Personalized Medicine - Euro Cancer 2024 (Italy)
- Cancer Pharmacology - Cancer Drugs 2024 (Canada)
- Cancer Pharmacology - Euro Cancer 2024 (Italy)
- Cancer Prevention - Euro Cancer 2024 (Italy)
- Cancer Prevention & Research - Cancer Meeting Summit 2025 (France)
- Cancer Prevention and Early Detection - CANCER THERAPY MEETING 2024 (France)
- Cancer Prevention and Early Detection: The Nurse’s Role - World Cancer 2025 (UK)
- Cancer Prevention and Risk Reduction - CANCER2025 (Netherlands)
- Cancer Prevention Vaccines - Cancer Drugs 2024 (Canada)
- Cancer Research - Euro Cancer 2024 (Italy)
- Cancer Science - Cancer Science 2024 (Italy)
- Cancer screening - CANCER THERAPY MEETING 2024 (France)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2025 (France)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (Netherlands)
- Cancer Therapy - Cancer Science 2024 (Italy)
- Cancer Therapy - Euro Cancer 2024 (Italy)
- Cancer Treatment and Therapeutics - World Cancer 2025 (UK)
- Cancer Treatments - Euro Cancer 2024 (Italy)
- Cancer Vaccines - CANCER THERAPY MEETING 2024 (France)
- Cancer Vaccines - Cancer Meeting Summit 2025 (France)
- Cancer Vaccines and Personalized Immunization Strategies - Cancer Biology 2025 (UK)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (Netherlands)
- Cancer: Lifestyle Connection and Nutrition - Euro Cancer 2024 (Italy)
- Cancers Pharmacology - Cancer Science 2024 (Italy)
- Cancers Pharmacology - Cancer Science 2024 (Italy)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (Netherlands)
- Carcinogenesis&Cancer Cell Biology - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Cardiovascular Biomarker Innovations - Biomarkers Conference 2025 (Italy)
- Case Studies - Breast Cancer 2024 (France)
- Case Studies - ORAL CANCER SUMMIT 2025 (France)
- Cell-Based Therapy - CANCER THERAPY MEETING 2024 (France)
- Cellular Mechanisms of Drug Resistance in Cancer - Cancer Biology 2025 (UK)
- Cellular Senescence and Tumor Suppression - Cancer Biology 2025 (UK)
- Cellular Therapies in Cancer Treatment - Cancer Biology 2025 (UK)
- Clinical and Medical Case Reports - Cancer Drugs 2024 (Canada)
- Clinical case studies and reports - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Clinical oncology& Radiation oncology - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (Netherlands)
- Clinical Trials and Research Innovations - World Cancer 2025 (UK)
- Collaboration and Networking in Cancer Research - CANCER THERAPY MEETING 2024 (France)
- CRISPR and Gene Editing in Cancer Therapy - Cancer Biology 2025 (UK)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Netherlands)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Netherlands)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Netherlands)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Netherlands)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Netherlands)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Netherlands)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Netherlands)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Netherlands)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Netherlands)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Netherlands)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Netherlands)
- Diagnostic Imaging in Cancer: Innovations and Future Directions - Preventive Oncology 2025 (Italy)
- Diet and Lifestyle Effect on Breast Cancer - Breast Cancer 2024 (France)
- DNA Damage and Mutation - Cancer Drugs 2024 (Canada)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2025 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2024 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Early Detection and Diagnostic - ORAL CANCER SUMMIT 2025 (France)
- Early Detection and Prevention - World Cancer 2025 (UK)
- Early Detection and Screening Innovations - CANCER2025 (Netherlands)
- Emerging Technologies in Cancer Research - World Cancer 2025 (UK)
- Environmental Biomarkers - Biomarkers Conference 2025 (Italy)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (Netherlands)
- Epidemiology - ORAL CANCER SUMMIT 2025 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2024 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer Summit 2025 (Italy)
- Epigenetic Biomarkers - Biomarkers Conference 2025 (Italy)
- Epigenetic Modifications and Cancer Treatment - Cancer Biology 2025 (UK)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Netherlands)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2024 (France)
- Ethical Considerations in Cancer Research and Treatment - CANCER THERAPY MEETING 2024 (France)
- Ethics in Biomarker Research - Biomarkers Conference 2025 (Italy)
- Exosomes and Cell Communication in Cancer Therapy - Cancer Biology 2025 (UK)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2024 (France)
- Future Directions in Oral Cancer Therapy - ORAL CANCER SUMMIT 2025 (France)
- Future Trends in Biomarker Research - Biomarkers Conference 2025 (Italy)
- Genetic and Environmental Factors in Cancer Development - Preventive Oncology 2025 (Italy)
- Genomic Biomarkers - Biomarkers Conference 2025 (Italy)
- Genomics and Cancer Epigenetics - CANCER2025 (Netherlands)
- Geriatric Oral Oncology - ORAL CANCER SUMMIT 2025 (France)
- Gynaecological Cancers - Cancer Meeting Summit 2025 (France)
- Gynecologic Cancer Prevention and Control - CANCER THERAPY MEETING 2024 (France)
- Head and Neck Cancer - Euro Cancer 2024 (Italy)
- Hematology- Oncology - Cancer Science 2024 (Italy)
- Hematology- Oncology - Euro Cancer 2024 (Italy)
- Immunotherapy and Cancer Vaccines - CANCER2025 (Netherlands)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Immunotherapy and Personalized Medicine in Oncology - Cancer Biology 2025 (UK)
- Infectious Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Netherlands)
- Inflammatory Breast Cancer - Breast Cancer 2024 (France)
- Inflammatory Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Inflammatory Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2024 (France)
- Innovations in Cancer Diagnostics and Early Detection - Preventive Oncology 2025 (Italy)
- Innovations in Cancer Education and Public Awareness - CANCER THERAPY MEETING 2024 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2024 (France)
- Innovative Treatment - ORAL CANCER SUMMIT 2025 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2024 (France)
- Interventional radiology (IR) - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Leukemia/Blood cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Liquid Biopsies for Precision Oncology - Cancer Biology 2025 (UK)
- Liquid Biopsies in Oncology - Biomarkers Conference 2025 (Italy)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (Netherlands)
- Lung Cancer - Euro Cancer 2024 (Italy)
- Male Breast Cancer Research - Breast Cancer 2024 (France)
- Male Breast Cancer Research - Breast Cancer Summit 2025 (Italy)
- Mammography - Breast Cancer 2024 (France)
- Managing Cancer Care & Patient Support - Cancer Drugs 2024 (Canada)
- Medications - ORAL CANCER SUMMIT 2025 (France)
- Metabolic Reprogramming in Cancer Cells - Cancer Biology 2025 (UK)
- Metastatic breast Cancer - Breast Cancer Summit 2025 (Italy)
- MicroRNA and Cancer - Cancer Drugs 2024 (Canada)
- Molecular and Genetic Insights in Oral Cancer - ORAL CANCER SUMMIT 2025 (France)
- Molecular Biology of Cancer - World Cancer 2025 (UK)
- Molecular Oncology: From Bench to Bedside - Preventive Oncology 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Monitoring Chronic Disease with Biomarkers - Biomarkers Conference 2025 (Italy)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Nanotechnology in Cancer Treatment - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2025 (France)
- Neuro-Oncology - Euro Cancer 2024 (Italy)
- Neurodegenerative Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2025 (France)
- Novel Screening Methods for Early Detection - Preventive Oncology 2025 (Italy)
- Nursing Leadership and Professional Development in Oncology - World Cancer 2025 (UK)
- Nutrition, Lifestyle, and Cancer Prevention - Preventive Oncology 2025 (Italy)
- Oncogenomics - Cancer Science 2024 (Italy)
- Oncology - Euro Cancer 2024 (Italy)
- Oncology Nursing and Care - Cancer Science 2024 (Italy)
- Oncology Nursing and Patient Care - CANCER2025 (Netherlands)
- Oncology Nursing Care - Cancer Meeting Summit 2025 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2025 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2025 (France)
- Oral Cavity Melanoma - ORAL CANCER SUMMIT 2025 (France)
- Organ Specific Cancer - Cancer Science 2024 (Italy)
- Organ Specific Cancer - Euro Cancer 2024 (Italy)
- Organ Specific Cancer - Cancer Meeting Summit 2025 (France)
- Palliative Care and Quality of Life - CANCER2025 (Netherlands)
- Pediatric Biomarkers - Biomarkers Conference 2025 (Italy)
- Pediatric Oncology - Cancer Drugs 2024 (Canada)
- Pediatric Oncology - World Cancer 2025 (UK)
- Pediatric Oncology Innovations - CANCER2025 (Netherlands)
- Pediatric oral cancer - ORAL CANCER SUMMIT 2025 (France)
- Personalized Cancer Medicine and Targeted Therapy - Preventive Oncology 2025 (Italy)
- PET Scans in High-Risk Populations for Cancer Prevention - Preventive Oncology 2025 (Italy)
- Pharma-Oncology - CANCER THERAPY MEETING 2024 (France)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (Netherlands)
- Precision Medicine and Biomarkers - Biomarkers Conference 2025 (Italy)
- Precision Medicine and Personalized Therapies - CANCER THERAPY MEETING 2024 (France)
- Precision Oncology and Disparities (Implementation and Discovery) - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Precision Oncology and Personalized Medicine - CANCER2025 (Netherlands)
- Precision Oncology: Targeting Cancer at the Molecular Level - Cancer Biology 2025 (UK)
- Prevention Strategies - ORAL CANCER SUMMIT 2025 (France)
- Preventive Oncology in Low- and Middle-Income Countries - Preventive Oncology 2025 (Italy)
- Prostrate Cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Proteomics in Biomarker Discovery - Biomarkers Conference 2025 (Italy)
- Psychiatric Biomarkers - Biomarkers Conference 2025 (Italy)
- Psychosocial Oncology and Mental Health - CANCER2025 (Netherlands)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2024 (France)
- Public Health Strategies in Reducing Cancer Burden - Preventive Oncology 2025 (Italy)
- Radiation Oncology - Cancer Science 2024 (Italy)
- Radiation Oncology - Euro Cancer 2024 (Italy)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (Netherlands)
- Radiation Therapy - Euro Cancer 2024 (Italy)
- Radiation Treatment - ORAL CANCER SUMMIT 2025 (France)
- Radiology - Breast Cancer 2024 (France)
- Radiology & Imaging Technologies - Cancer Drugs 2024 (Canada)
- Radiopharmaceuticals & Pharmacokinetics - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Rare Cancers and Orphan Drugs - CANCER2025 (Netherlands)
- Regenerative Medicines - Cancer Drugs 2024 (Canada)
- Rehabilitation - ORAL CANCER SUMMIT 2025 (France)
- RNA-based Therapies in Cancer - Cancer Biology 2025 (UK)
- Robotic Oncology - Cancer Drugs 2024 (Canada)
- Role of AI and Machine Learning in Cancer Diagnosis - Preventive Oncology 2025 (Italy)
- Role of AI in Cancer - Euro Cancer 2024 (Italy)
- Role of Artificial Intelligence in Precision Cancer Treatment - Cancer Biology 2025 (UK)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Netherlands)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Netherlands)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2024 (France)
- Role of Nutrition in Oral Cancer Management - ORAL CANCER SUMMIT 2025 (France)
- Role of Organoids and 3D Cultures in Personalized Cancer Treatment - Cancer Biology 2025 (UK)
- Role of Stem Cells in Cancer Progression and Treatment - Cancer Biology 2025 (UK)
- Sarcoma - Euro Cancer 2024 (Italy)
- Skin Cancer - Cancer Science 2024 (Italy)
- Skin Cancer - Euro Cancer 2024 (Italy)
- Squamous cell carcinoma - ORAL CANCER SUMMIT 2025 (France)
- Stem Cell Therapy - Cancer Science 2024 (Italy)
- Stem Cell Transplantation (Bone Marrow Transplantation) - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Supportive Care and Palliative Medicine - World Cancer 2025 (UK)
- Surgical & Clinical Oncology - Cancer Drugs 2024 (Canada)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2025 (France)
- Surgical Oncology - Cancer Science 2024 (Italy)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (Netherlands)
- Targeted Cancers Therapy - Cancer Science 2024 (Italy)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (Netherlands)
- Targeting Cancer Cell Cycle for Therapeutic Advances - Cancer Biology 2025 (UK)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Netherlands)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Netherlands)
- Telemedicine and Digital Health in Oncology - CANCER2025 (Netherlands)
- Therapeutic Targeting of Cancer - RADIOLOGY AND ONCOLOGY 2024 (UAE)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Translational Biomarker Research - Biomarkers Conference 2025 (Italy)
- Translational Research and Clinical Applications - CANCER THERAPY MEETING 2024 (France)
- Treatment of Cancer - CANCER THERAPY MEETING 2024 (France)
- Tumor Biology - Cancer Science 2024 (Italy)
- Tumor Heterogeneity and Personalized Treatment Approaches - Cancer Biology 2025 (UK)
- Tumor Immunology - Cancer Science 2024 (Italy)
- Tumor Microenvironment and Its Role in Cancer Progression - Preventive Oncology 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (Netherlands)
- Tumor virology - Cancer Science 2024 (Italy)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2025 (France)
- Types of Cancer - Euro Cancer 2024 (Italy)
- Verrucous carcinoma - ORAL CANCER SUMMIT 2025 (France)